About Empirica Therapeutics
Empirica Therapeutics is a company based in Hamilton (Canada) founded in 2018 by Jason Moffat was acquired by Century Therapeutics in June 2020.. Empirica Therapeutics operates in a competitive market with competitors including Imvax, GT Medical Technologies, Basilea, Laminar Pharma and SOM Biotech, among others.
- Headquarter Hamilton, Canada
- Founders Jason Moffat
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Century Therapeutics
(Jun 23, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Empirica Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Empirica Therapeutics
Empirica Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Century Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of adult stem cells to develop therapies for cancer
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Empirica Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Empirica Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Empirica Therapeutics Comparisons
Competitors of Empirica Therapeutics
Empirica Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imvax, GT Medical Technologies, Basilea, Laminar Pharma and SOM Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient-specific cell vaccines for glioma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for brain tumor radiation therapy are provided.
|
|
| domain | founded_year | HQ Location |
Antibiotics, antifungals, and oncology drugs are developed for disease treatment.
|
|
| domain | founded_year | HQ Location |
Melipathy-based drugs are developed for cancer, Alzheimer's, and inflammation treatments.
|
|
| domain | founded_year | HQ Location |
Developer of platform for screening compounds to treat rare diseases
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for cancer, eye, and infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Empirica Therapeutics
When was Empirica Therapeutics founded?
Empirica Therapeutics was founded in 2018.
Where is Empirica Therapeutics located?
Empirica Therapeutics is headquartered in Hamilton, Canada. It is registered at Hamilton, Ontario, Canada.
Who is the current CEO of Empirica Therapeutics?
Sheila Singh is the current CEO of Empirica Therapeutics.
What does Empirica Therapeutics do?
Empirica Therapeutics was founded in 2018 and is based in Hamilton, Canada. T-cell based therapeutics are developed by the company for brain cancer treatment within the biotechnology sector. Operations focus on genetically engineered T cells equipped with chimeric antigen receptors that target the CD133 antigen to identify and eliminate cancer cells. The lead product, eCAR-133, is advanced through preclinical and clinical stages to address unmet needs in oncology.
Who are the top competitors of Empirica Therapeutics?
Empirica Therapeutics's top competitors include Imvax, GT Medical Technologies and Basilea.
Who are Empirica Therapeutics's investors?
Empirica Therapeutics has 1 investor. Key investors include Century Therapeutics.